arGEN-X advances a third therapeutic antibody program into preclinical development: http://t.co/hBB8aUOQ
posted 17 hours ago
FlandersBio’s board of directors has 18 members and is composed of representatives from different life sciences companies, biotech institutes & hospitals, capital providers and service companies.











